MYC and colorectal carcinoma: In addition, data demonstrated that disruption of intestinal Bmal1 accelerated the heterozygosity (LOH) of APC, and Wnt/β-catenin signalling was aberrantly activated, enhancing MYC-dependent glycolytic metabolism to accelerate CRC progression [45].